R. Sutherland

8.5k total citations · 1 hit paper
133 papers, 7.1k citations indexed

About

R. Sutherland is a scholar working on Molecular Biology, Molecular Medicine and Oncology. According to data from OpenAlex, R. Sutherland has authored 133 papers receiving a total of 7.1k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 34 papers in Molecular Medicine and 32 papers in Oncology. Recurrent topics in R. Sutherland's work include Antibiotic Resistance in Bacteria (34 papers), Estrogen and related hormone effects (26 papers) and Cancer-related Molecular Pathways (23 papers). R. Sutherland is often cited by papers focused on Antibiotic Resistance in Bacteria (34 papers), Estrogen and related hormone effects (26 papers) and Cancer-related Molecular Pathways (23 papers). R. Sutherland collaborates with scholars based in Australia, United Kingdom and United States. R. Sutherland's co-authors include Elizabeth A. Musgrove, G. N. Rolinson, C. K. W. Watts, Michael F. Buckley, Anna DeFazio, Robert I. Nicholson, Kimberley J. E. Sweeney, John A. Hamilton, Rina Hui and E.A.P. Croydon and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

R. Sutherland

131 papers receiving 6.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Expression and amplification of cyclin genes in human breast cancer.

1993 583 citations Kimberley J. E. Sweeney, Anna DeFazio et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
R. Sutherland	3.2k	2.6k	1.7k	1.1k	949	133	7.1k
Karen Brown	3.1k 1.0×	1.4k 0.5×	1.5k 0.9×	1.0k 1.0×	471 0.5×	184	8.8k
Shrikant Anant	5.3k 1.7×	2.2k 0.8×	840 0.5×	1.5k 1.4×	445 0.5×	212	9.3k
Cornelius Knabbe	2.8k 0.9×	1.6k 0.6×	1.4k 0.8×	819 0.8×	197 0.2×	226	6.9k
Yonghong Xiao	2.8k 0.9×	945 0.4×	798 0.5×	690 0.6×	439 0.5×	159	5.9k
Mong‐Hong Lee	6.7k 2.1×	3.6k 1.4×	1.1k 0.6×	1.7k 1.6×	167 0.2×	103	10.0k
Judith E. Karp	6.3k 2.0×	4.6k 1.8×	787 0.5×	1.4k 1.3×	357 0.4×	275	14.2k
Harris Bernstein	2.9k 0.9×	1.2k 0.4×	1.3k 0.8×	449 0.4×	159 0.2×	109	5.5k
Yong Sang Song	4.2k 1.3×	2.3k 0.9×	758 0.4×	2.3k 2.2×	488 0.5×	431	11.9k
Volkhard Kaever	4.4k 1.4×	524 0.2×	1.7k 1.0×	200 0.2×	965 1.0×	204	7.7k
I Pastan	4.7k 1.5×	8.4k 3.2×	480 0.3×	271 0.3×	483 0.5×	48	10.8k

Countries citing papers authored by R. Sutherland

Since Specialization

Citations

This map shows the geographic impact of R. Sutherland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Sutherland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Sutherland more than expected).

Fields of papers citing papers by R. Sutherland

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Sutherland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Sutherland. The network helps show where R. Sutherland may publish in the future.

Co-authorship network of co-authors of R. Sutherland

This figure shows the co-authorship network connecting the top 25 collaborators of R. Sutherland. A scholar is included among the top collaborators of R. Sutherland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Sutherland. R. Sutherland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Byrom, Bill, et al.. (2022). POSC429 Clinical Trial Site Attitudes and Experiences in Managing BYOD ePRO: Results of a Qualitative Study. Value in Health. 25(1). S277–S277. 1 indexed citations

Roberts, Caroline G. P., Ewan K.A. Millar, Sandra O’Toole, et al.. (2011). Identification of PUMA as an estrogen target gene that mediates the apoptotic response to tamoxifen in human breast cancer cells and predicts patient outcome and tamoxifen responsiveness in breast cancer. Oncogene. 30(28). 3186–3197. 23 indexed citations

Barton, Caroline, Brian Gloss, Aaron L. Statham, et al.. (2009). Collagen and calcium-binding EGF domains 1 is frequently inactivated in ovarian cancer by aberrant promoter hypermethylation and modulates cell migration and survival. British Journal of Cancer. 102(1). 87–96. 37 indexed citations

Tan, Ern Yu, Leticia Campo, Chengcheng Han, et al.. (2009). The key hypoxia regulated gene CAIX is upregulated in basal-like breast tumours and is associated with resistance to chemotherapy. British Journal of Cancer. 100(2). 405–411. 165 indexed citations

Sutherland, R., et al.. (2009). BAG-1 overexpression attenuates luminal apoptosis in MCF-10A mammary epithelial cells through enhanced RAF-1 activation. Oncogene. 29(4). 527–538. 21 indexed citations

Cooper, Wendy A., Maija R.J. Kohonen‐Corish, Charles Chan, et al.. (2008). Prognostic significance of DNA repair proteins MLH1, MSH2 and MGMT expression in non‐small‐cell lung cancer and precursor lesions. Histopathology. 52(5). 613–622. 47 indexed citations

Millar, Ewan K.A., Catriona M. McNeil, Sandra O’Toole, et al.. (2008). BAG-1 predicts patient outcome and tamoxifen responsiveness in ER-positive invasive ductal carcinoma of the breast. British Journal of Cancer. 100(1). 123–133. 33 indexed citations

Sweeney, Kimberley J. E., Elizabeth A. Musgrove, Colin Watts, & R. Sutherland. (1996). Cyclins and breast cancer. Cancer treatment and research. 83. 141–170. 16 indexed citations

Sutherland, R., et al.. (1996). Expression of the androgen receptor and an androgen-responsive protein, apolipoprotein D, in human breast cancer. British Journal of Cancer. 74(8). 1175–1180. 62 indexed citations

10.

Sutherland, R.. (1995). β-Lactam/β-lactamase inhibitor combinations: Development, antibacterial activity and clinical applications. Infection. 23(4). 191–200. 23 indexed citations

11.

Hu, Xiangdong, M. Veroni, M. De Luise, et al.. (1993). Circumvention of tamoxifen resistance by the pure anti‐estrogen ICI 182, 780. International Journal of Cancer. 55(5). 873–876. 95 indexed citations

12.

Cohen, Alan, Emma Davies, Kimberly Evans, et al.. (1992). Influence of the Royal College of Radiologists' guidelines on hospital practice: a multicentre study. Royal College of Radiologists Working Party.. BMJ. 304(6829). 740–743. 33 indexed citations

13.

Sutherland, R., et al.. (1992). Bactericidal effects of co-amoxidav (amoxycillin clavnlanic acid) against a Legionella pneumophila pneumonia in the immnnocompromised weanling rat. Journal of Antimicrobial Chemotherapy. 30(4). 525–534. 11 indexed citations

14.

Cohen, Alan, Emma Davies, Kimberly Evans, et al.. (1991). A multicentre audit of hospital referral for radiological investigation in England and Wales. Royal College of Radiologists Working Party.. BMJ. 303(6806). 809–812. 22 indexed citations

15.

Händel, M., Anna DeFazio, C. K. W. Watts, Richard O. Day, & R. Sutherland. (1991). Inhibition of DNA Binding and Transcriptional Activity of a Nuclear Receptor Transcription Factor by Aurothiomalate and Other Metal Ions. Molecular Pharmacology. 40(5). 613–618. 23 indexed citations

16.

Wilkinson, M. J., et al.. (1991). Bactericidal effects of amoxyciffin/clavulanic acid against a Legionella pneumophila pneumonia in the weanling rat. Journal of Antimicrobial Chemotherapy. 27(1). 127–136. 12 indexed citations

17.

Slocombe, B, et al.. (1989). Bactericidal effects of amoxycillin/clavulanic acid against Legionella pneumophila. Journal of Antimicrobial Chemotherapy. 23(1). 43–51. 13 indexed citations

18.

Sutherland, R., E.A.P. Croydon, & G. N. Rolinson. (1972). Amoxycillin: A new Semi-synthetic Penicillin. BMJ. 3(5817). 13–16. 138 indexed citations

19.

Knudsen, Elisa, G. N. Rolinson, & R. Sutherland. (1967). Carbenicillin: a new semisynthetic penicillin active against Pseudomonas pyocyanea.. BMJ. 3(5557). 75–78. 94 indexed citations

20.

Sutherland, R., et al.. (1967). Laboratory and pharmacological studies in man with hetacillin and ampicillin.. BMJ. 2(5555). 804–808. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact